Psychopharmacology Books

Book SynopsisMyrna Chandler Goldstein, MA, has been a freelance writer and independent scholar for more than 30 years. She is the coauthor of Pain Management: Fact versus Fiction (Greenwood, 2022) and Dietary Supplements: Fact versus Fiction (Greenwood, 2020), among others.Mark A. Goldstein, MD, is the founding chief emeritus of the Division of Adolescent and Young Adult Medicine at Massachusetts General Hospital and Associate Professor of Pediatrics at Harvard Medical School. He is also the editor in chief of Current Pediatrics Reports.

Read more less

Book SynopsisNow in a revised and updated third edition, this noted practitioner guide and text incorporates the latest knowledge about psychopharmacology and collaborative care. Therapists and counselors learn when and how to make medication referrals and how to address patients' questions about drug benefits, side effects, safety, and more. Organized around frequently encountered mental health disorders, the book explains how medications work (including what they can and cannot accomplish). Strategies for collaborating successfully with patients, their family members, and prescribers are discussed in detail. Written for optimal practical utility, the text features case examples, sample referral letters, checklists, and a glossary. New to This Edition *Chapter on the therapeutic relationship. *New separate chapter on bipolar disorder. *Expanded discussions of distinguishing psychiatric illness from normal distress, optimizing collaboration with psychiatrists, how mediTrade Review​"All psychotherapists practicing today, whether independently or in community settings, must be informed about psychopharmacology. This superb book covers how to talk to patients and their families about medication and collaborate with prescribers. The third edition is up to date and exceptionally well written, and covers the diagnostic ground from anxiety and depression to psychosis and cognitive disorders. I cannot think of a book that better achieves its purpose of educating non-MD mental health practitioners and graduate students to be as helpful as possible to their patients who are taking, or may need, psychoactive medication."--Stanley B. Messer, PhD, Distinguished Professor Emeritus and former Dean, Graduate School of Applied and Professional Psychology, Rutgers, The State University of New Jersey "The third edition of this guide gives psychotherapists both a systemic conceptual framework and the latest science about psychotropic medications and how they work. The distinguished trio of Patterson, Griffith, and Edwards emphasize the essential need for collaboration between therapists and prescribing clinicians. This book provides everything you need to know about medications' effects on the brain and behavior when used in conjunction with behavioral interventions for common psychiatric disorders."--Susan H. McDaniel, PhD, ABPP, Dr. Laurie Sands Distinguished Professor of Families and Health, University of Rochester Medical Center “This book is a gem. It is the best book that I’ve seen that provides beginning and seasoned nonmedical clinicians with essential information about psychopharmacology with a spectrum of mental health conditions. What sets this book apart is the authors' use of a systems and collaborative care framework that includes patients and key family members as valuable resources. Written in an exceptionally practical and accessible style with wonderful case illustrations, the book is a superb reference for clinicians working in integrated healthcare and private practice settings. I highly recommend this volume as an excellent basic teaching text for graduate students across mental health disciplines."--John S. Rolland, MD, MPH, Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine "This book is extremely well suited to those who have no prior knowledge of psychopharmacology or wish to build on their existing knowledge. The text is a professor's dream--is clearly laid out, builds sequentially on previous learning, and incorporates the latest developments in the field. This is one of those rare publications that students in the helping professions should keep on their shelves long after graduation. I have relied on this book over the years in a variety of academic and clinical settings, and remain impressed by its clarity, practicality, and relevance."--Sarah A. Bond, PsyD, Solana Beach, California-Provides a wealth of information to individuals in the helping professions to assist them in better understanding the link between medications and therapy for a variety of diagnoses....This text is an exceptional reference guide for the therapist. The information provided is explained in a straightforward format and is easy to understand and use in one's work with families. In addition, this book would be a wonderful faculty reference or text for students in courses that focus on psychological disorders. (on the first edition)--Family Journal, 10/1/2007ƒƒThe book offers practical guidance to providers--information that can be used both to influence therapists' work and to pass along to their clients....A valuable resource. (on the first edition)--PsycCRITIQUES, 8/15/2007ƒƒA clear, understandable and helpful book for the nonphysician wishing to be more conversant within this field. (on the first edition)--Child and Family Behavior Therapy, 6/1/2007ƒƒThe authors have written one of the best books available on psychopharmacology by providing detailed information in a user-friendly format for all mental health clinicians....Academics and practicing clinicians will, without a doubt, keep this book within reach for daily use. I will recommend this book to all of my colleagues….5 Stars! (on the first edition)--Doody's Review Service, 7/27/2007ƒƒA must-have text for clinicians, and will help them provide the best standard of care to their patients and clients. (on the second edition)--Metapsychology Online Reviews, 8/30/2011Table of ContentsI. The Mind–Body Connection 1. How the Brain Works: A Basic Sketch 2. How Psychotropic Drugs Work II. Psychiatric Disorders and Their Treatment 3. Depression 4. Bipolar Disorder 5. Anxiety Disorders 6. Schizophrenia and Other Psychoses 7. Cognitive Disorders 8. Alcoholism and Substance Abuse 9. Physical Health and Illness 10. Special Populations III. Creative Collaboration 11. The Therapeutic Relationship 12. Effective Referrals 13. Sharing Care 14. Strengthening Bonds Glossary References Index

Read more less

Book SynopsisChallenging an exclusively medical approach to mental health and illness, this book considers the impact psychiatric drugs can have on spirituality. In the last thirty years, a dramatic rise in medication as a treatment for mental illness has occurred in tandem with increasing numbers of people entering treatment with a spiritually-oriented understanding of their suffering. The unforeseen result is that some people taking psychiatric drugs are engaging with them in ways that can have a profound impact on the course and outcome of treatment. Based on interviews with people on psychiatric medication who regard spirituality as significant in their lives, this book reveals how medication can be perceived as both helpful and harmful to spirituality. The author argues that spirituality must be considered in debates around psychopharmacology.Trade ReviewSocietal debate about psychiatric drugs usually focuses on whether the drugs are "effective" or do more "good than harm". In this well-written, thoughtful book, Lynne Vanderpot explores the effects of psychiatric medications through a different lens: how do the medications affect one's subjective experience of being alive, and more particularly, one's internal experience of a spiritual life? Hers is a thoughtful, clear exploration of an important subject, and on every page her respect for the users of these medications and the diversity of their experiences shines through. -- Robert Whitaker, journalist and author of 'Anatomy of an Epidemic'Drawing on twenty compelling personal stories, Vanderpot attends to a fundamental, yet neglected problem - how and why psychiatric medications either enhance or inhibit healing spiritual responses to profound emotional suffering. The data highlight the troubling myopia of exclusively biological explanations and treatments of mental illness. Here you will learn just how a range of life contingencies differently shape our perceptions and experiences of pain, pills and personhood. Many readers, grabbed by its numerous striking insights, will themselves be transformed by this innovative volume. -- David A. Karp, Professor Emeritus of Sociology at Boston College and author of 'Is It Me or My Meds? Living with Antidepressants'Unlike doctors, people who take psychiatric medication measure the success of their treatment not just on clinical outcomes, but on how the drugs affect the totality of their lives. That includes spirituality-the search for meaning and purpose, as well as the feeling of connectedness to self, others, and the divine. Vanderpot's book is sensitively written and uniquely focused, a valuable addition to the conversation about the use of medication in the real world. -- Katherine Sharpe, author of Coming of Age on Zoloft (Harper Perennial, 2012)In exploring the relationship between spirituality and medication, Vanderpot invites both the prescribers of medication and the recipients of the medication to reflect more deeply on the person's life as a whole, a body-mind-spirit individual. To truly know a person in this way requires time. Unfortunately in the current limits of 15' medication sessions, a significant relationship cannot be established and the person suffers. All that is of value to them is not explored. Hopefully, this book can help us challenge the problems and dangers inherent in such limited encounters. -- Nancy Kehoe RSCJ, PhD, author of 'Wrestling with Our Inner Angels: Faith, Mental Illness and the Journey to Wholeness'Anyone interested in psychiatric medication and spirituality and how they interact in people's lives should read this excellent book. It is well researched and an easy and engaging read. It raises some truly important questions about how we view and treat human suffering including the impact of psychiatric medicine on the whole person. -- Professor William West, University of ChesterIn this thought-provoking book, Vanderpot makes the compelling case that the question of whether or not to use psychiatric drugs is more than simply a routine 'treatment' decision, but rather entails a sacred process of deep self-exploration. Drawing keen insights from the stories of those who have grappled deeply with this issue, Vanderpot invites us to consider the profound impact that psychiatric drug treatment has on the deepest levels of one's being, a question that becomes increasingly important as psychiatric drug use continues to escalate in the world today. -- Paris Williams, PhD., Clinical Psychologist and author of 'Rethinking Madness'Table of ContentsPrologue. 1. Hallowed be thy tablets. 2. Understanding Spirituality. 3. Understanding Psychopharmacology. 4. Medication Enhances Spirituality. 5. Medication Hinders Spirituality. 6. Rich Times for Rethinking the World. 7. Conclusion/Hope. Appendix.

Read more less

Book SynopsisThis is a different kind of book about psychedelics. Rather than describing psychedelic experiences, it presents four future-oriented ideas ''coming over the psychedelic horizon'', which illustrate the potential benefits of psychedelics for humanity: # Stanislav Grof''s view of our minds as a way to understand works of art (looking at Disney's Snow White). # The evidence that psychedelic-occasioned mystical experiences can boost our immune systems. # Psychedelics as a way of adding new cognitive programmes to our thinking skills. # Applying the ideas from Part 3 to learning.

Read more less

Book SynopsisA nuanced portrait of a daring subculture that continues to push the limits of religious experience and intellectual possibility.Trade ReviewAltered States genuinely moves forward in laying a path for new, insightful, and valuable information on the American Buddhism that is developing in our global society. Douglas Osto's groundbreaking research will be appreciated by scholars, and his accessible style will be enjoyed by nonacademic readers. -- Charles Prebish, author of Luminous Passage: The Practice and Study of Buddhism in America Altered States deftly guides us through the neglected territory of psychedelic Buddhism. This is a fascinating story, full of vivid characters and supported by solid research. Still, I believe it makes a greater contribution by situating these practices and persons within the larger contexts of tantra, of American religion, and of cutting-edge neuropsychology and consciousness studies. The result is-to use le mot juste-mind blowing. -- Franz Metcalf, author of What Would Buddha Do?: 101 Answers to Life's Daily Dilemmas "[Altered States] mixes statistics and surveys, historical overview, personal experience, and ethnographic texture to uncover the intertwining history of two fast-growing movements in American spirituality... This overview will appeal to anyone interested in Buddhism, psychedelic possibilities, and understanding how both are forging a controversial new American religious experience. Publishers Weekly Provocative... The book is worth buying, reading, and quoting. PsycCritiquesTable of ContentsPreface Acknowledgments Introduction 1. Buddhism and the Psychedelic Connection 2. The Psychedelic Revolution 3. The Buddhist Revolution 4. Opening the Door: Psychedelics as a Gateway to Buddhist Practice 5. Closing the Door: The Fifth Precept and Graduating from Psychedelics 6. Keeping the Door Open: Psychedelics as an Adjunct to Buddhist Practice 7. Are Psychedelics "the True Dharma"?: Debates, Presuppositions, and Philosophical Issues Conclusions Postscript Notes Bibliography Index

Read more less

Book SynopsisPsychotropic drugs are used widely with the elderly, but formal knowledge and training are often poor. With a focus on geriatric considerations such as medical issues, disabilities and nursing-home situations, this handbook gives clinicians the facts they need to work with elderly clients.

Read more less

Book Synopsis"Dr. Paris has written an honest, balanced presentation of the waysin which psychiatric drugs are evaluated and prescribed. Hehighlights the complexity of the task, the limits of what is knownand the mixed picture that research often produces.Trade Review“The Use and Misuse of Psychiatric Drugs deserves a place in every health sciences library.” (Metapsychology Online Reviews, 8 January 2013) "In the book’s foreword, Tyrer describes this book as a ‘‘well balanced sober account of a serious issue that affects almost all of us in one way or another’’ and I would agree with that. The book is well written, easy to read, and makes good bedtime reading despite the serious nature of its topic. Epidemiologists will find it useful as background to the use of these medications, even if observational studies were neglected. ... Paris is not afraid to tackle controversial topics and make forceful statements about issues where improvement is needed. I highly recommend this book to anyone who would like to know more about this topic." (Annals of Epidemiology, 2012)Table of ContentsForeword. Introduction. Part I OVERVIEW. 1 The History of Psychopharmacology. 2 The Science of Psychopharmacology. 3 The Pharmaceutical Industry. Part II DRUGS IN PRACTICE. 4 Antipsychotics: For Better or For Worse. 5 Mood Stabilizers and Mood Instability. 6 Antidepressants. 7 Prescribing for Children and Adolescents. 8 Polypharmacy. Part III PERSPECTIVES. 9 Alternatives to Drugs. 10 Medicalizing Distress. 11 The Future of Psychopharmacology. References. Index.

Read more less

Book SynopsisThis book fulfils an urgent need for an updated text on pediatric psychopharmacology. It takes a unique approach in discussing recent findings within the context of current issues, including economic and political ones. The book covers the emerging question of treating children who do not yet meet diagnostic criteria for psychosis, e.g, schizophrenia or bipolar disorder, but who are deemed to be at high risk. This is an active area of debate: such children are being treated in certain centers, while others reject this completely. The book addresses the antidepressant controversy, the placebo response and unique strategies for delineating this, and ways to optimize the differential between active medication and placebo. It reviews the impact of recent American Heart Association guidelines for monitoring children on stimulants and other psychotropics. It adheres closely to DSM-IV diagnostic criteria throughout. The book describes the use of newly approved drugs such as Lexapro for treatiTrade Review “Pharmacotherapy of Child and Adolescent Psychiatric Disorders is a book to have available on your desk, not just in your library. It provides ready access to the wealth of practical information and insight for the range of health and mental health professionals. It is highly recommended for trainees and anyone who is prescribing psychotropic medications to the pediatric population and young adults.” (Journal of Clinical Psychiatry, 7 July 2012) Table of ContentsList of Contributors, xv Foreword, xix Chapter 1 Historical Perspectives on Child and Adolescent Psychopharmacology, 1 Samuel Gershon References, 4 Chapter 2 Pharmacoepidemiology of Psychotropic Medications in Youth, 7 Daniel J. Safer & Julie Magno Zito Introduction, 7 Prevalence and trends for medications prescribed for ADHD, 8 Nonstimulant medications for ADHD, 11 Antidepressant medication, 11 Antipsychotic medication, 13 Alpha-agonists, 14 Anticonvulsant "mood stabilizers", 15 Concomitant psychotropic medication, 15 Preschool psychotropic medication use, 17 International patterns of psychotropic medication for youth, 17 Conclusion, 18 References, 18 Chapter 3 Off-Label Prescribing of Drugs in Child and Adolescent Psychiatry, 25 C. Lindsay DeVane Introduction, 25 Extent of off-label prescribing, 27 Need for psychoactive drug treatments for children and adolescents, 31 Legislation supporting pediatric drug development, 33 Recommendations to follow when considering off-label prescribing, 35 References, 36 Chapter 4 The Use of Generic Drugs in Pediatric Psychopharmacology, 39 Richard I. Shader & Christopher-Paul Milne What is a generic drug?, 39 Why are we discussing generic drugs?, 39 Basic requirements for generic drugs, 40 The status of regulations regarding generic drugs and children, 41 Abbreviated new drug application (ANDA) requirements, 42 Pediatric assessments of adult drugs (history up to current status), 43 Best Pharmaceuticals for Children Act, 44 Pediatric Research Equity Act, 45 Intersection of requirements for generics and pediatric assessment, 46 Future directions, 48 Concluding thoughts, 49 References, 49 Chapter 5 Psychoactive Drug Use in Children: Basic Concepts in Clinical Pharmacology, 51 David J. Edwards Introduction, 51 Basic concepts in pharmacokinetics, 52 Dosing considerations for psychoactive drugs in children, 55 Summary, 60 References, 60 Chapter 6 Psychostimulants, 65 Steven R. Pliszka Introduction, 65 Epidemiology of stimulant use, 66 Structure and biochemical mechanism of action, 66 Neuroimaging studies of stimulant effects, 67 Studies of short-term efficacy, 72 Studies of long-term efficacy, 76 Clinical use, 79 Common side-effects, 84 Cardiovascular safety issues, 86 Growth suppression, 88 Substance use and diversion, 88 Comparison with nonstimulant treatment, 89 Treatment of comorbidity, 92 Pharmacogenetics, 93 Conclusions, 94 References, 94 Chapter 7 Tricyclic Antidepressants and Monoamine Oxidase Inhibitors for the Treatment of Child and Adolescent Psychiatric Disorders, 105 Charlotte M. Heleniak, Tejal Kaur, Kareem D. Ghalib & Moira A. Rynn Tricyclic antidepressants (TCAs), 105 Drug interactions, contraindications, 116 Monoamine oxidase inhibitors (MAOIs), 117 General summary, 122 References, 123 Chapter 8 Selective Serotonin Reuptake Inhibitors (SSRIs), 131 Dara Sakolsky & Boris Birmaher Pharmacokinetics, 131 Initiation and titration, 133 Indications and efficacy, 134 Adverse effects, 146 Withdrawal, 149 References, 149 Chapter 9 Novel (Atypical) Antidepressants, 155 Heidi R. Bruty, Graham J. Emslie & Paul Croarkin Novel (atypical) antidepressants, 155 General overview, 155 Bupropion, 157 Duloxetine, 162 Mirtazapine, 164 Trazodone, 166 Venlafaxine, 170 Desvenlafaxine, 173 Alternative treatments, 174 Summary, 175 References, 176 Chapter 10 Antipsychotic Agents, 181 Brieana M. Rowles, John L. Hertzer & Robert L. Findling Introduction, 181 Chemical properties, 182 Typical antipsychotics, 183 Atypical antipsychotics, 186 Ethical issues: treatment of at-risk populations, 212 Conclusions, 213 References, 213 Chapter 11 Lithium, 221 Garrett M. Sparks & David A. Axelson Introduction, 221 Pharmacology, 222 Potential mechanisms of action, 222 Evidence for the use of lithium in children and adolescents, 232 Dosing and drug monitoring, 239 Contraindications, precautions, and drug interactions, 242 Side-effects, 246 References, 250 Chapter 12 Anticonvulsants Used in Child and Adolescent Psychiatric Disorders, 261 Mani Pavuluri & Tushita Mayanil Introduction, 261 Divalproex sodium, 261 Carbamazepine, 271 Oxcarbazepine, 275 Lamotrigine, 279 Gabapentin, 284 Topiramate, 285 Conclusion, 288 References, 288 Chapter 13 Anxiolytics, 301 Barbara J. Coffey & Amanda L. Zwilling Chemical properties, 301 Indications, 305 Contraindications, 320 Adverse effects, 321 Overdose, 324 Abuse/dependence, 324 Drug interactions, 325 Available preparations and cost, 325 Initiation and maintenance of treatment, 325 Management of specific side-effects, 330 How to withdraw medication, 332 References, 332 Chapter 14 Adrenergic Agents in Child and Adolescent Psychiatry, 341 Lawrence David Scahill Clonidine and guanfacine, 341 Guanfacine, 349 Beta-blockers, 355 Acknowledgements, 361 References, 361 Chapter 15 Atypical Psychopharmacologic Strategies, 365 Jess Shatkin & Aron Janssen Opiate antagonists, 365 Memantine, 368 Riluzole, 369 Secretin, 371 Topiramate, 372 Herbal medications and dietary supplements, 373 Ginkgo (Ginkgo biloba), 375 Melatonin, 381 Omega-3 fatty acids, 383 St. John's wort (Hypericum perforatum), 384 Valerian (Valeriana officinalis), 387 Conclusion, 388 References, 389 Chapter 16 Psychopharmacology in Preschool Children, 399 Mini Tandon & Joan Luby Introduction, 399 Developmental considerations, 400 Rise in psychopharmacology use, 402 Psychotherapy before psychopharmacology, 403 When psychopharmacology may be considered as a first line: pragmatic considerations, 404 Psychopharmacology in preschool disorders: administration and monitoring, 404 Off-label prescribing: special considerations, 407 Use of psychotropics in specific disorders, 408 Summary, 415 References, 415 Chapter 17 Combination Pharmacotherapy for Psychiatric Disorders in Children and Adolescents, 421 Gagan Joshi & Anna M. Georgiopoulos Bipolar disorder, 422 Major depressive disorder, 429 Attention-deficit hyperactivity disorder, 431 Obsessive-compulsive disorder, 433 Tics and Tourette's syndrome, 434 Pervasive developmental disorders, 434 Conclusion, 434 References, 435 Index, 439

Read more less

Book SynopsisFROM PLACEBO TO PANACEA With the latest generation of psychoactive drugs, has pharmacologyat last triumphed over mental illness? A close look at worldscientific literature would suggest otherwise. The sobering truthis that many claims about the efficacy of drug therapies foreverything from depression to schizophrenia have been exaggerated.What, then, accounts for the inflated confidence clinicians and thelay public alike often have in the new generation of wonderdrugs? Find out in From Placebo to Panacea. From Placebo to Panacea is not an indictment of drug therapy.Rather, it is a reasoned analysis of the efficacy of psychoactivedrugs as compared to other forms of treatment--backed by hardempirical data. Above all, it is meant to function as a therapist''sand patient''s guide to making more informed decisions whenconsidering treatment options. The book begins with an in-depth discussion of salient problemswith standard methods of measuring the usefulness of pTable of ContentsPartial table of contents: CONCEPTUAL ISSUES. The Curse of the Placebo: Fanciful Pursuit of a Pure BiologicalTherapy (S. Fisher & R. Greenberg). Treatment Implications of Psychiatric Comorbidity (M.Greenberg). Costly Compromises: A Critique of the Diagnostic and StatisticalManual of Mental Disorders (R. Carson). EFFICACIES OF PSYCHOACTIVE DRUGS FOR ADULTS. A Critique of the Use of Neuroleptic Drugs in Psychiatry (D.Cohen). A Focused Empirical Analysis of Treatments for Panic and Anxiety(W. Danton & D. Antonuccio). EFFICACIES OF PSYCHOACTIVE DRUGS FOR CHILDREN. Are We Justified in Treating Children with PsychoactiveDrugs? (R. Fisher & S. Fisher). Stimulant Pharmacotherapy for Attention- Deficit/HyperactivityDisorders: An Analysis of Progress, Problems, and Prospects (C.Whalen & B. Henker). OVERVIEW. What Are We to Conclude About Psychoactive Drugs?: Scanning theMajor Findings (S. Fisher & R. Greenberg). Indexes.

Read more less

Book SynopsisRecent years have seen major advances in the understanding andtreatment of health anxiety and hypochondriasis, particulary inrelation to the cognitive behavioural approach to anxiety. Thisvolume brings together this knowledge of psychological andpharmacological treatments of health anxiety, and relates it to aconceptual framework which provides a basis for assessment,treatment and ongoing research. Asmundson, Taylor and Cox have assembled a group of world classscientists and practitioners for this book. The chapters provide awealth of information on the causes, assessment and treatment ofhealth anxiety related disorders. I believe that their book is themost significant contribution to date to our understanding ofhealth anxiety related disorders. Everyone working in the healthfield will find something of worth in this book. G. Ron Norton, Ph.D, Professor Emeritus, University of Winnipeg,CanadaTrade Review"...This book will give you the current status in the field from aninternational perspective..." (Int Jnl of Adolescent MedicalHealth, Vol.14, No.3, 2002) "...It is well structured, clearly written and provides anexcellent and comprehensive overview of the subject..."(British Journal of Clinical Psychology, September 2002)Table of ContentsAbout the Editors. List of Contributors. Foreword: Professor S. Rachman. Preface. Acknowledgments. PART I: CLINICAL FEATURES AND THEORETICAL PERSPECTIVES. 1. Health Anxiety: Classification and Clinical Features (Gordon J.G. Asmundson, Steven Taylor, Serperi Sevgur, and Brian J.Cox). 2. The Psychology of Physical Symptoms and Illness Behavior (ReneMartin, Katherine Lemos, and Howard Leventhal). 3. Making Sense of Hypochondriasis: A Cognitive Theory of HealthAnxiety (Paul M. Salkovskis and Hillary Warwick). 4. Personality Traits and Health Anxiety (Erin McClure and Scott O.Lilienfeld). PART II: ASSESSMENT AND TREATMENT. 5. Assessment of Health Anxiety (Sherry Stewart and Margo C.Watt). 6. Hypochondriasis: Boundaries and Comorbidities (Russell Noyes,Jr.). 7. Integrated Approach to Cognitive-Behavioral Therapy for IntenseIllness Worries (Patricia Furer, John R. Walker, and Mark H.Freeston). 8. Pharmacological Management of Hypochondriasis and RelatedDisorders (Murray W. Enns, Kevin Kjernisted, and MarkLander). 9. General and Cross-Cultural Considerations in a Medical Settingfor Patients Presenting with Medically Unexplained Symptoms (JavierI. Escobar, Lesley A. Allen, Constanza Hoyos Nervi, and Michael A.Gara). 10. Hypochondriasis and Health Anxiety in the Elderly (Allison G.Snyder and Melinda A. Stanley). PART III: RELATED CONDITIONS. 11. Heart-focussed Anxiety in Medical and Anxiety-relatedPsychological Conditions (Georg H. Eifert, Michael J. Zvolensky,and Carl W. Lejuez). 12. Hypochondriasis and Health Anxiety among Pain Patients (HeatherD. Hadjistavropoulos, Katherine M. B. Owens, ThomasHadjistavropoulos, and Gordon J. G. Asmundson). 13. Psychotic Disorders with Hypochondriacal Features: Delusions ofthe Soma (David Kingdon, Shanaya Rathod, and DouglasTurkington). 14. Death Anxiety (Robert J. Kastenbaum). PART IV: CONCLUSIONS AND FUTURE DIRECTIONS. 15. Future Directions and Challenges in Assessment, Treatment, andInvestigation (Gordon J. G. Asmundson, Steven Taylor, Kristi D.Wright, and Brian J. Cox). Author Index. Subject Index.

Read more less

Book SynopsisTreatment with drugs is fundamental to modern therapy of psychiatric disorders. The number of disorders responsive to drug treatment is increasing, reflecting the extensive synthesis of novel compounds and the greater understanding of the aetiology of the disorders. This third edition provides new and updated material, including an additional chapter on clinical trials and their importance in assessing the efficacy and safety of psychotropic drugs. As molecular biology and imaging techniques are of increasing importance to basic and clinical neuroscience, these areas have also been extended to illustrate their relevance to our understanding of psychopharmacology. This book is essential reading for undergraduates in pharmacology and the neurosciences, postgraduate neuropharmacologists, psychiatrists in training and in practice and medical researchers. Reviews of the Second Edition this text is eminently readable, well researched, and probably the best of Trade Review“…one of the best in the area of psychopharmacology…well written, concise and easy to understand with clear and informative figures and tables…highly recommended. (Human Psychopharmacology, Vol.20, No.1, January 2005)Table of ContentsPreface to Third Edition. Preface to Second Edition. Preface to First Edition. Introduction. 1. Functional Neuroanatomy of the Brain. 2. Basic Aspects of Neurotransmitter Function. 3. Pharmacokinetic Aspects of Psychopharmacology. 4. Clinical Trials and Their Importance in Assessing the Efficacy and Safety of Psychotropic Drugs. 5. Molecular Genetics and Psychopharmacology. 6. Psychotropic Drugs that Modify the Serotonergic Systems. 7. Drug Treatment of Depression. 8. Drug Treatment of Mania. 9. Anxiolytics and the Treatment of Anxiety Disorders. 10. Drug Treatment of Insomnia. 11. Drug Treatment of Schizophrenia and the Psychoses. 12. Drug Treatment of the Epilepsies. 13. Drug Treatment of Parkinson's Disease. 14. Alzheimer's Disease and Stroke: Possible Biochemical Causes and Treatment Strategies. 15. Psychopharmacology of Drugs of Abuse. 16. Paediatric Psychopharmacology. 17. Geriatric Psychopharmacology. 18. The Inter-relationship Between Psychopharmacology and Psychoneuroimmunology. 19. Endocoids and Their Importance in Psychopharmacology. Appendix 1: Some Important Psychotropic Drug Interactions. Appendix 2: Glossary of Some Common Terms Used in Psychopharmacology. Appendix 3: Generic and Proprietary Names of Some Common Psychotropic Drugs. Appendix 4: Key References for Further Reading. Index.

Read more less

Book SynopsisDas Lehrbuch listet die Krankheitsbilder anhand der ICD-10-Klassifikationen auf und stellt die psychischen Störungen hinsichtlich ihrer Epidemiologie, Psychopathologie, Ätiologie und Diagnostik, aber auch neuartiger Therapiekonzepte dar. Viele Fallbeispiele dienen dabei der Vertiefung und helfen bei der Einprägung des Stoffs. Eingeflossen sind neueste Forschungsergebnisse aus der Pharmakologie, Psychotherapie und biologischen Psychiatrie. Das Lehrbuch begleitet die Einarbeitung in das Fachgebiet während des Studiums oder in der Facharztausbildung.Trade Review“... Untermauert werden die jeweiligen Themen mit Diagrammen, Tabellen und etwaigen Fallbeispielen. Am Ende jedes Kapitels sind Vorschläge für weiterführende Literatur zu den jeweiligen Störungen aufgelistet. ... Sehr hilfreich ist das Glossar am Ende des Buches mit Erklärungen vieler psychiatrischer und psychopathologischer Fachausdrücke. ... Dieses Buch ist geeignet für Medizinstudenten, die sich tief in die Thematik einarbeiten wollen. ... Es geht sehr ins Detail und ist so umfassend, dass es für Assistenten in der Weiterbildung, Ärzte, Psychologen, Psychotherapeuten empfehlenswert ist.” (in: Fachschaft Medizin LMU München, fachschaft-medizin.de, Dezember 2015)“... zahlreiche Tabellen, die verschiedenste Sachverhalte ... der Schreibstil ist sehr angenehm und leicht verständlich ... Das Buch ist besonders für Medizinstudierende in ... sehr empfehlenswert ...“ (Thomas Schütz, in: Medizinische Universität Innsbruck, skalpell.at,11.März 2015)“... Zielgruppe: Medizinstudenten, Assistenten in der Weiterbildung, Ärzte, Psychologen, Psychotherapeuten ... Das Lehrbuch Psychiatrie ist für Studierende der Medizin durchaus empfehlenswert, wenn auch sehr umfangreich. ... Wer in das Gebiet der Psychiatrie ein bisschen tiefer einsteigen möchte, ist mit diesem Lehrbuch bestimmt gut beraten.“ (in: Fachschaft Medizin Marburg, fs-medizin.de, 30. März 2015)“… Die Informationen im Buch werden ergänzt durch Tabellen und Flussdiagramme, welche komplizierte Sachverhalte erleichtern und bei Behandlungsschemata die zeitliche Reihenfolge. Auch Kategorisierungen und Klassifikationen werden durch die Nutzung von Tabellen deutlich überischtlicher. ... einen strukturierten und detaillierten Einstieg in die Psychiatrie bekommen, welcher außerdem viel Wert auf klinische Bezüge legt ...“ (in: Fachschaft Medizin Münster, fsmed-muenster.de, 2.Januar 2015) “... der Aufbau ist gut gelungen, man findet schnell und übersichtlich alle Informationen oder Stichworte, die man sucht. ... Die meisten relevanten Themen sind enthalten und auch sehr gut erklärt. ...“ (in: Veasyte, S 62, Wintersemester 2014-2015)“... überarbeitete und aktualisierte Lehrbuch richtet sich an Studierende der Medizin sowie an in Ausbildung befindlichen Psychiaterinnen, Psychologinnen und Psychotherapeutinnen, aber auch an bereits Praktizierende sowie an Vertreterinnen der Nachbardisziplinen Neurologie, Innere Medizin, Pädiatrie, Pädagogik und Pflegewissenschaften ... die Komplexität des Fachgebiets in leichtverständlicher, aber gleichzeitig spannender Form darstellen ...” (Anita Riecher-Rössler, in: Schweizer Archiv für Neurologie und Psychiatrie, Swiss Archives of Neurology & Psychiatry, 2014, Vol. 165, Issue 1, S. 33)Table of Contents Einführung Organische einschließlich symptomatischer psychischer Störungen Psychische und Verhaltensstörungen durch psychotrope Substanzen Schizophrenie, schizotype und wahnhafte Störungen Affektive Störungen Neurotische Belastungs- und somatoforme Störungen Verhaltensauffälligkeiten mit körperlichen Störungen und Faktoren Essstörungen nicht organische Schlafstörungen nicht organische sexuelle Funktionsstörungen psychische und Verhaltungsstörungen im Wochenbett Missbrauch von nicht abhängigkeitserzeugenden Substanzen Persönlichkeits- und Verhaltensstörungen Kinder- und Jugendpsychiatrie Gerontopsychiatrie Suizidales Verhalten Schmerz Psychiatrische Notfall Psychotherapeutische Verfahren Grundzüge der Sozialpsychiatrie Psychiatrische Rehabilitation Grundzüge der Konsilliar/Liaison Psychiatrie Forensische Psychiatrie

Read more less

Book SynopsisThis volume gives an overview of new insights to alcohol pharmacology using DREADDs (Designer Receptors and Unraveling the Neuropharmacology of Alcohol). It examines which pharmacological principles should be applied to understanding DREADDs taking into account some very current research. Additionally, this book covers important topics under the heading of “experimental pharmacology” and alcohol.Table of ContentsPart 1. Neurotransmitter systems.- 1. GABAA receptor subtype mechanism and the abuse related effects of ethanol: Genetic and pharmacological evidence.- 2. Presynaptic Ethanol Actions: Potential Roles in Ethanol Seeking.- 3. Dynamic adaptation in neurosteroid networks in response to alcohol.- 4. GABA and Glutamate synaptic co-adaptations to chronic ethanol in the striatum.- 5. The cerebellar GABAAR system as a potential target for treating alcohol use disorder.- 6. Do alcohol-related AMPA-type glutamate receptor adaptations promote intake?.- 7. Molecular, neuronal and behavioral effects of ethanol and nicotine interactions.- 8. Cross-species alterations in synaptic dopamine regulation after chronic alcohol exposure.- 9. Central noradrenergic interactions with alcohol and regulation of alcohol related behaviors.- Part 2. Ion Channels.- 10. Voltage-sensitive calcium channels in the brain: Relevance to alcohol intoxication and withdrawal.- 11. Voltage-sensitive potassium channels of the BK type and their coding genes are alcohol targets in neurons.- 12. Chronic alcohol, intrinsic excitability, and potassium channels: Neuroadaptations and drinking behavior.- Part 3. Neuroimmune system.- 13. Hepatic immune system adaptations to alcohol.- 14. Innate immune signaling and alcohol use disorders.- 15. Cytokins in the CNS.- Part 4. Neuropeptides and Genomics.- 16. Corticotropin Releasing Factor (CRF) Neurocircuitry and neuropharmacology in alcohol drinking.- 17. Contribution of dynorphin and orexin neuropeptide systems to the motivational effects of alcohol.- 18. Transcriptional regulators as targets for alcohol pharmacotherapies.- Part 5. Pharmacotherapy.- 19. Advances in Pharmacotherapy Development From Preclinical Animal Studies.- 20. Advances in Pharmacotherapy Development: Human Clinical Studies.

Read more less

Book Synopsis

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book SynopsisThe Stahl''s Illustrated books are a series of pocket-sized, mid-priced, themed volumes. They distil theoretical information from the Stahl''s Essential Psychopharmacology volume and combine this with practical data from The Prescriber''s Guide. They are illustration heavy and designed to encourage speedy learning of both concepts and applications. The visual learner will find that these books make the concepts easier to master, and the non-visual learner will appreciate the clear, shortened text on complex psychopharmacological concepts. This volume covers the latest developments in our understanding of post-traumatic stress disorder and anxiety. As well as covering the full range of management options, there is a specific focus on the implications for military populations. The Stahl''s Illustrated series appeals to the widest possible audience of mental health professionals, and not just those with expertise in psychopharmacology.Table of Contents1. Neurobiology of stress and anxiety; 2. Post-traumatic stress disorder (PTSD); 3. Neurotransmitter systems as pharmacological targets for PTSD; 4. First-line medications for PTSD; 5. Second-line, adjunct, and investigational medications for PTSD; 6. Cognitive behavioral therapy (CBT) for PTSD; 7. Caring for patients with PTSD; 8. Unique considerations for the military population; Summary.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Pediatric and Adolescent Psychopharmacology A | BookCurl

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book SynopsisThis pocket-sized volume in the Stahl's Illustrated series combines theoretical information from Stahl's Essential Psychopharmacology with practical data from The Prescriber's Guide. This highly-illustrated guide presents the underlying neurobiology, genetic predisposition and management of aggressive behaviours in patients with psychiatric disorders.Table of ContentsPreface; CME information; Objectives; Introduction; 1. Which individuals will become violent or aggressive?; 2. Neurobiology and genetics of violence and aggression; 3. Treatment of violence and aggression; Summary; References; Index; CME: posttest and certificate.

Read more less

Book Synopsis

Read more less

Book SynopsisTrade Review"This is an excellent resource. Chapters are clearly and efficiently written. With the move towards digital communication, access to the website version is very helpful." -Aaron Plattner, MD (Pine Rest Christian Mental Health Services) Doody's Score: 96 - 4 Stars!

Read more less

Book SynopsisCombining medication and cognitive behavioral therapy (CBT) can be challenging but can also enhance patient care. This book reviews the existing literature about the neurobiological and clinical basis in combining CBT and medication for non-psychiatrist mental health clinicians.Trade Review"Perhaps the most valuable aspect of the book, though, are the guidelines for collaborative care and the professional socialization provided as to how important it is for providers to establish trust and communicate well. There is a good discussion of how to set up collaborative relationships and of the kinds of information and policies that providers should share." (PsycCRITIQUES, Volume 56, Issue 51)Table of ContentsPreface v 1 Medication Versus CBT: How Did That Happen? 1 2 Neurobiological Evidence and Combined Treatment 9 3 Dual Responsibility Treatment: Principles That Facilitate Collaborative Patient Care 19 4 Combining CBT Interventions and Medication to Enhance Medication Adherence 35 5 Combined Treatment for Major Depression 55 6 Combined Treatment for Bipolar Disorder 81 7 Combined Treatment for Anxiety Disorders 103 8 Combined Treatment for Eating Disorders 119 9 Combined Treatment for Schizophrenia 139 10 Combined Treatment for Borderline Personality Disorder 159 11 Combined Treatment in Pregnancy 181 12 Combined Treatment for Substance Abuse and Dependence—written with Samson Gurmu, M.D. 193 References 209 Author Index 235 Subject Index 243

Read more less

Book SynopsisNow in paperback. In the tradition of Lori Gottlieb and Henry Marsh, a distinguished psychiatrist examines his own practice. Alastair Santhouse knew something was wrong the night he was on call during his medical training and got the news that a woman on the way to the ER had died in the ambulance. That meant he could go back to sleep! But he couldn't. He was overtaken with the sense that his joyful reaction was terrible failure. That night began his long journey away from the ER and into psychiatry. Head First chronicles Santhouse's many years treating patients and his exploration of the ways in which our minds exert a huge and underappreciated influence over our health. They shape our responses to symptoms that we develop, dictate the treatments we receive, and influence whether they work. They even influence whether we develop symptoms at all. Written with brutal honesty, deep compassion, and a wry sense of humor, Head First examines difficult cases that illuminate some of our most puzzling and controversial medical issues--from the tragedy of suicide, to the stigma surrounding obesity, to the mysteries of self-induced illness. Ultimately he finds that our medical model has failed us by promoting specialization and overlooking perhaps the single most important component of our health: our state of mind. 

Read more less

Book Synopsis

Read more less